Researchers continue to excited about the medication , a novel dual agonist showing significant outcomes in clinical trials for weight reduction . It works by impacting both systems: GLP-1 and GIP, https://lulunejn978388.bloginwi.com/74567989/this-new-prospect-for-size-loss